OBJECTIVES: To assess the accuracy of real-time myocardial contrast perfusion imaging (MCPI) for the diagnosis of restenosis and extent of coronary artery disease (CAD) in patients with previous percutaneous coronary intervention (PCI). METHODS: 56 patients were studied 1.9 (SD 1.4) years after PCI. They underwent MCPI with commercially available ultrasound contrast agents (Optison or Definity) at rest and at peak dobutamine-atropine stress. Coronary angiography was performed within one month. Significant CAD was defined as >or= 50% stenosis in >or= 1 major epicardial coronary artery. Significant restenosis was defined as >or= 50% stenosis in a coronary segment with previous intervention. RESULTS: Reversible perfusion abnormalities were detected in 40 of 43 patients with significant CAD and in 4 of 13 patients without (overall sensitivity 93%, 95% CI 85% to 99%; specificity 69%, 95% CI 44% to 94%; and accuracy 88%, 95% CI 79% to 96%). Significant restenosis in >or= 1 coronary artery with previous PCI was detected in 38 (68%) patients. Reversible perfusion abnormalities were present in 35 of them (sensitivity 92%, 95% CI 84% to 99%). Reversible perfusion abnormalities were detected in >or= 2 vascular distributions in 20 of 28 patients with multivessel CAD and in 3 of 28 patients without (sensitivity 71%, 95% CI 55% to 88%; specificity 89%, 95% CI 78% to 99%; and accuracy 80%, 95% CI 70% to 91%). Restenosis was detected in 41 coronary arteries. Sensitivity of MCPI for regional diagnosis of restenosis was 73% (95% CI 60% to 87%), specificity was 75% (95% CI 60% to 90%), and accuracy was 74% (95% CI 64% to 84%). CONCLUSION: Dobutamine stress MCPI is a useful technique for the evaluation of restenosis and extent of CAD after PCI.
OBJECTIVES: To assess the accuracy of real-time myocardial contrast perfusion imaging (MCPI) for the diagnosis of restenosis and extent of coronary artery disease (CAD) in patients with previous percutaneous coronary intervention (PCI). METHODS: 56 patients were studied 1.9 (SD 1.4) years after PCI. They underwent MCPI with commercially available ultrasound contrast agents (Optison or Definity) at rest and at peak dobutamine-atropine stress. Coronary angiography was performed within one month. Significant CAD was defined as >or= 50% stenosis in >or= 1 major epicardial coronary artery. Significant restenosis was defined as >or= 50% stenosis in a coronary segment with previous intervention. RESULTS: Reversible perfusion abnormalities were detected in 40 of 43 patients with significant CAD and in 4 of 13 patients without (overall sensitivity 93%, 95% CI 85% to 99%; specificity 69%, 95% CI 44% to 94%; and accuracy 88%, 95% CI 79% to 96%). Significant restenosis in >or= 1 coronary artery with previous PCI was detected in 38 (68%) patients. Reversible perfusion abnormalities were present in 35 of them (sensitivity 92%, 95% CI 84% to 99%). Reversible perfusion abnormalities were detected in >or= 2 vascular distributions in 20 of 28 patients with multivessel CAD and in 3 of 28 patients without (sensitivity 71%, 95% CI 55% to 88%; specificity 89%, 95% CI 78% to 99%; and accuracy 80%, 95% CI 70% to 91%). Restenosis was detected in 41 coronary arteries. Sensitivity of MCPI for regional diagnosis of restenosis was 73% (95% CI 60% to 87%), specificity was 75% (95% CI 60% to 90%), and accuracy was 74% (95% CI 64% to 84%). CONCLUSION:Dobutamine stress MCPI is a useful technique for the evaluation of restenosis and extent of CAD after PCI.
Authors: I Kósa; R Blasini; J Schneider-Eicke; F J Neumann; I Matsunari; J Neverve; A Schömig; M Schwaiger Journal: J Nucl Med Date: 1998-08 Impact factor: 10.057
Authors: Jeane M Tsutsui; Abdou Elhendy; Feng Xie; Edward L O'Leary; Anna C McGrain; Thomas R Porter Journal: J Am Coll Cardiol Date: 2005-04-19 Impact factor: 24.094
Authors: Abdou Elhendy; Edward L O'Leary; Feng Xie; Anna C McGrain; James R Anderson; Thomas R Porter Journal: J Am Coll Cardiol Date: 2004-12-07 Impact factor: 24.094
Authors: A Elhendy; M L Geleijnse; J R Roelandt; R T van Domburg; P R Nierop; J J Bax; J D Kasprzak; G M el-Said; M M Ibrahim; P M Fioretti Journal: Nucl Med Commun Date: 1997-02 Impact factor: 1.690
Authors: Piet K Vanhoenacker; Isabel Decramer; Olivier Bladt; Giovanna Sarno; Erik Van Hul; William Wijns; Ben A Dwamena Journal: BMC Med Imaging Date: 2008-07-31 Impact factor: 1.930